Watson Rebecca’s Eli Lilly LLY Stock Holding History

Watson Rebecca’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-629	Closed	-$103K	–	243
2020 Q2	$103K	Buy	+629	New	+$96.6K	0.06%	111

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Watson Rebecca's LLY Position: Q3 2020 in Review

Watson Rebecca sold out of Eli Lilly (LLY) in Q3 2020, closing a stake of 629 shares — an estimated $103K sold.

Watson Rebecca first reported a position in LLY in Q2 2020 and held it in 1 quarter. The position peaked at $103K in Q2 2020. 1,774 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

Watson Rebecca reported no remaining Eli Lilly position as of Q3 2020 after selling out during the quarter.
Watson Rebecca sold 629 Eli Lilly shares in Q3 2020, an estimated $103K.
Watson Rebecca first reported a position in Eli Lilly in Q2 2020 and held it in 1 quarter.
Watson Rebecca's Eli Lilly position peaked at $103K in Q2 2020.
1,774 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.